ARWR Arrowhead Pharmaceuticals Inc.

3.55
+0.04  (1%)
Previous Close 3.51
Open 3.49
Price To book 2.93
Market Cap 265440966
Shares 74,772,103
Volume 692,300
Short Ratio 5.22
Av. Daily Volume 1,239,928

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Announced that development will be discontinued - November 29, 2016.
ARC-AAT
Alpha-1 antitrypsin deficiency (AATD)
Announced that development will be discontinued - November 29, 2016.
ARC-521
Chronic Hepititis B (HBV)
Announced that development will be discontinued - November 29, 2016.
ARC-520 injection in combination with entecavir or tenofovir
Chronic Hepititis B (HBV)

Latest News

  1. Here's What Caused Arrowhead Pharmaceuticals' Stock to Spike Today
  2. Today's Research Reports on Trending Tickers: Aldeyra Therapeutics and Arrowhead Pharmaceuticals
  3. Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM™ Platform and Lead RNAi-based Drug Candidates
  4. ETFs with exposure to Arrowhead Pharmaceuticals, Inc. : September 12, 2017
  5. Arrowhead to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
  6. Arrowhead Pharmaceuticals, Inc. :ARWR-US: Earnings Analysis: Q3, 2017 By the Numbers : September 8, 2017
  7. Arrowhead Pharmaceuticals to Host R&D Day on RNAi-Based Therapies
  8. Edited Transcript of ARWR earnings conference call or presentation 3-Aug-17 8:30pm GMT
  9. Today’s Research Reports on Stocks to Watch: Horizon Pharma and Arrowhead Pharmaceuticals
  10. Arrowhead Reports Fiscal 2017 Third Quarter Results
  11. Investor Network: Arrowhead Pharmaceuticals, Inc. to Host Earnings Call
  12. Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Third Quarter Results
  13. ETFs with exposure to Arrowhead Pharmaceuticals, Inc. : July 10, 2017
  14. Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
  15. ETFs with exposure to Arrowhead Pharmaceuticals, Inc. : May 26, 2017
  16. Edited Transcript of ARWR earnings conference call or presentation 3-May-17 8:30pm GMT
  17. Arrowhead Pharmaceuticals, Inc. :ARWR-US: Earnings Analysis: Q2, 2017 By the Numbers : May 5, 2017
  18. Today's Research Reports on Arrowhead Pharmaceuticals and Paratek Pharmaceuticals Post Earnings
  19. Arrowhead Reports Fiscal 2017 Second Quarter Results
  20. Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results